Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PIM1 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-13 |
mRNA | PRSS57 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
mRNA | SPN | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-09 |
mRNA | MTX1 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |
mRNA | CD69 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | MRPL9 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
mRNA | PSMD4 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-08 |
mRNA | CISH | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | LAPTM5 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-08 |
mRNA | SLC6A19 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |